Overcome The Challenges Of Small Batch Production While Maximizing Yield

Source: AST

By Joe Hoff, Automated Systems of Tacoma


A focus on niche drugs for targeted patient populations has led to an increase in small batch production across the pharmaceutical industry. These products include advanced therapy medicinal products (ATMPs) and high-value biologics that require very complex production processes or the use of expensive active pharmaceutical ingredients (APIs) that are often limited in supply. A minimal amount of available poses major challenges when filling a product, making process efficiency a critical factor in reducing waste and improving the yield for small batches of drug product.

access the Article!

Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Pharmaceutical Online? Subscribe today.

Subscribe to Pharmaceutical Online X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.


Subscribe to Pharmaceutical Online